[The chemotherapeutic use of antidiabetics. Sulfonylurea compounds and glinides].
Mark
Michael
M
Stoffwechselforschung Boehringer Ingelheim Pharma KG, 88397 Biberach. michael.mark@bc.boehringer-ingelheim.com
D000818:Animals; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D007328:Insulin / Q000378:metabolism; D010179:Pancreas / Q000187:drug effects / Q000378:metabolism; D013453:Sulfonylurea Compounds / Q000494:pharmacology / Q000627:therapeutic use*
D007004:Hypoglycemic Agents; D007328:Insulin; D013453:Sulfonylurea Compounds
Vom Chemotherapeutikum zum Antidiabetikum. Sulfonylharnstoffe und Glinide.